Metabolism of heterocyclic aromatic amines by human hepatocytes and cytochrome P4501A2.

[1]  A. Guillouzo,et al.  Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rat and human hepatocytes. , 2002, Carcinogenesis.

[2]  F. Guengerich,et al.  Metabolism of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in human hepatocytes: 2-amino-3-methylimidazo[4,5-f]quinoxaline-8-carboxylic acid is a major detoxification pathway catalyzed by cytochrome P450 1A2. , 2001, Chemical research in toxicology.

[3]  K. Kulp,et al.  Identification of urine metabolites of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine following consumption of a single cooked chicken meal in humans. , 2000, Carcinogenesis.

[4]  T. Sugimura,et al.  Nutrition and dietary carcinogens. , 2000, Carcinogenesis.

[5]  S R Tannenbaum,et al.  N-oxidative metabolism of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in humans: excretion of the N2-glucuronide conjugate of 2-hydroxyamino-MeIQx in urine. , 1999, Cancer research.

[6]  K. Turteltaub,et al.  Macromolecular adduct formation and metabolism of heterocyclic amines in humans and rodents at low doses. , 1999, Cancer letters.

[7]  K. Turteltaub,et al.  DNA and protein adduct formation in the colon and blood of humans after exposure to a dietary-relevant dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[8]  F. Guengerich,et al.  Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2. , 1998, Chemical research in toxicology.

[9]  A. Guillouzo,et al.  Liver cell models in in vitro toxicology. , 1998, Environmental health perspectives.

[10]  S. Leveson,et al.  Metabolism of the food-borne mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in humans. , 1998, Chemical research in toxicology.

[11]  H. Yamazaki,et al.  Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. , 1996, Cancer research.

[12]  A. Ronco,et al.  Meat, fat and risk of breast cancer: A case‐control study from Uruguay , 1996, International journal of cancer.

[13]  W. Willett,et al.  Diet, nutrition, and avoidable cancer. , 1995, Environmental health perspectives.

[14]  J. Holme,et al.  Metabolism of the food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat and other rodents. , 1995, Princess Takamatsu symposia.

[15]  J. Shaddock,et al.  Effect of glutathione depletion and inhibition of glucuronidation and sulfation on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) metabolism, PhIP-DNA adduct formation and unscheduled DNA synthesis in primary rat hepatocytes. , 1994, Carcinogenesis.

[16]  J. Groopman,et al.  The direct glucuronidation of 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine (PhIP) by human and rabbit liver microsomes. , 1993, Chemical research in toxicology.

[17]  W. Trager,et al.  Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline. , 1993, Chemical research in toxicology.

[18]  M. Knize,et al.  Heterocyclic-Amine Mutagens/Carcinogens in Foods , 1990 .

[19]  D. Kingston,et al.  Isolation, Structure Elucidation, and Synthesis of the Major Anaerobic Bacterial Metabolite of the Dietary Carcinogen 2-Amino-3,4-dimethyl-3H-imidazo[4,5-f]quinoline (meIQ) , 1989 .

[20]  S. Thorgeirsson,et al.  Metabolic activation of mutagenic heterocyclic aromatic amines from protein pyrolysates. , 1986, Critical reviews in toxicology.